Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04752332
Status:
TERMINATED
Last Update Posted:
2024-05-29
First Post:
2021-02-11
Brief Title:
A Study of Abemaciclib LY2835219 Plus Hormone Therapy in Participants With Early Breast Cancer
Sponsor:
Organization:
Eli Lilly and Company